Performance and Portfolio Update

Performance

  • The Pax Small Cap Fund outperformed the Russell 2000 Index during the third quarter.

Market Review

  • The portfolio’s outperformance was driven by stock selection in Information Technology and Industrials. Allocation provided a small headwind to performance, in part due to the portfolio’s use of the Sustainability Lens, which identifies areas of opportunity and risk related to the transition to a more sustainable economy. Several Sub-Industries in the Energy sector are classified as high-risk/low opportunity from a lens perspective, and these areas were among the best performing groups within the Russell 2000 universe.

Contributors

  • In the midst of a challenging macro environment, the top active contributors were driven by stock specific factors.
  • Karuna Therapeutics (Health Care) surged in August on the back of positive Phase III data related to its schizophrenia therapy.
  • Extreme Networks (Information Technology) reported stronger than expected top and bottom-line results, and guided revenue growth and EPS in the low to mid-teens for 2023, as the company continues to gain share from Cisco.
  • Si-Bone (Health Care) reported solid Q2 results, as management saw procedure volumes accelerate in the quarter and expects further growth in H2 and 2023. This view is bolstered by the continued expansion of the salesforce and recent reimbursement increases (which take effect in Q4).

Detractors

  • The worst performers were market specific, as opposed to being driven by a common theme.
  • Health Catalyst (Health Care) disappointed with weak Q2 results and forward guidance as the company signaled its hospital customers focusing on labor and other costs ahead of additional tech spending.
  • Cryoport (Healthcare) disappointed the street across the board with revenue and EPS misses and disappointing fiscal year guidance.
  • Brightsphere Investment Group (Financials) sold off as weaker equity markets lowered AUM and revenue expectations.

Outlook

  • Small cap stocks have declined sharply this year as slowing economic growth have reduced earnings expectations. The prospects of a recession and further interest rate increases by the Federal Reserve to reduce high inflation have weighed on investor sentiment, pressuring earnings multiples (valuations). Challenging markets can present opportunities for investors as selling pressure can be indiscriminate. Historically Impax has viewed these periods as opportunities to buy high quality companies for discounted valuations. While often difficult, periods like these require investors to tune out the noise, extend their time horizon and think about the opportunities at hand with an objective lens. Impax endeavors to do just that in the coming months.

Performance

(as of 9/30/22)
Returns (%)Average Annual Returns (%)
1-MonthQuarterYTD1 Year3 Year5 Year10 YearSince Inception1
Small Cap Fund – Investor Class-8.27-2.10-27.69-23.103.882.887.927.19
Small Cap Fund – Class A-8.36-2.18-27.76-23.163.872.867.917.19
Small Cap Fund – Institutional Class-8.34-2.14-27.62-22.954.123.128.18
7.46
Russell 2000 Index-9.58-2.19-25.10-23.504.293.558.557.68
Lipper Small-Cap Core Funds Index-9.51-4.17-22.58-18.035.154.448.837.89

Performance data quoted represent past performance, which does not guarantee future results. Investment return and principal value of an investment will fluctuate so that an investor’s shares, when redeemed, may be worth more or less than their original cost. Current performance may be lower or higher than the performance data quoted. For most recent month-end performance call 800.767.1729 or for more information visit impaxam.com.

Figures include reinvested dividends, capital gains distributions and changes in principal value.

As of 5/1/22 prospectus, total annual Small Cap Fund operating expenses, gross of any fee waivers or reimbursements, for Investor Class, Class A, and Institutional Class shares are 1.15%, 1.15% and 0.90%, respectively.

Performance
after sales charge

(as of 9/30/22)
Returns (%)Average Annual Returns (%)
1-MonthQuarterYTD1 Year3 Year5 Year10 YearSince Inception1
Small Cap Fund - Class A (Load)-13.42-7.54-31.71-27.381.931.707.306.77

1The inception date for the Pax Small Cap Fund Institutional Class and Investor Class is March 27, 2008. The inception date for the Class A shares is May 1, 2013.

The performance information shown for Class A represents the performance of the Investor Class shares for the period prior to Class A inception. Expenses have not been adjusted to reflect the expenses allocable to Class A shares. Class A inception date return since May 1, 2013, is 7.17% (annualized). A 1.00% CDSC (contingent deferred sales charge) may be charged on any shares sold within 18 months of purchase over $1 million. POP (public offering price) reflects the maximum sales load for the Fund’s Class A Shares of 5.50%.

Performance Attribution


(as of 9/30/22)
Sector: Average Active Weights (%)
Total Relative Contribution (%)

XOther: ETFs (for short-term cash mgmt. purposes) and Cash & Equivalents.
Past performance is no guarantee of future results.

Portfolio Characteristics

(as of 9/30/22)
FundBenchmark
Market Cap (weighted avg.)$3,479M$2,527M
Forward Price/Earnings14.5310.48
ROE9.557.06
Beta
0.801.00
Number of Securities591,970

Top Ten Holdings

(as of 9/30/22)
Victory Capital Holdings, Inc., Class A 4.0%, Ligand Pharmaceuticals, Inc. 3.5%, Eastern Bankshares, Inc. 3.1%, Healthcare Realty Trust, Inc. 3.1%, SI-BONE, Inc. 3.0%, Graphic Packaging Holding Company 2.9%, Neurocrine Biosciences, Inc. 2.8%, BrightSphere Investment Group, Inc. 2.7%, Voya Financial, Inc. 2.6%, Pacira Biosciences, Inc. 2.5%. Holdings are subject to change.

Definitions

ƒWeighted Average is an average in which each quantity to be averaged is assigned a weight. These weightings determine the relative importance of each quantity on the average.
~Forward Price-Earnings Ratio or P/E FY1 ratio is a ratio for valuing a company that measures its current share price relative to its per-share earnings over the next 12 months.
°Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation’s profitability by revealing how much profit a company generates with the money shareholders have invested.
A historical Beta is used for Funds with greater than 2 years of performance history under the same mandate. Ten-year Beta is used. Beta reflects the sensitivity of a Fund’s return to fluctuations in its benchmark; a beta for a benchmark is 1.00; a beta greater than 1.00 indicates above-average volatility and risk.

The statements and opinions expressed are those of the author as of the date of this report. All information is historical and not indicative of future results and subject to change. This information is not a recommendation to buy or sell any security. Past performance does not guarantee future results.

IMPX1264 (1/23)

Nathan Moser, CFA®

Senior Portfolio Manager

Nathan Moser is a Senior Portfolio Manager at Impax Asset Management LLC, the North American division of Impax Asset Management Group and investment adviser to Pax World Funds. He is Senior Portfolio Manager of the US Small Cap Strategy, including the Pax Small Cap Fund. Nathan has been a member of the Pax Sustainable Allocation Fund portfolio management team since 2015.

Nathan has managed the Pax Small Cap Fund since its inception in 2008, which is the year he joined the firm. Prior to that, he worked at Citizens Funds, first as an Equity Analyst then as a Portfolio Manager. Nathan started his career with John Hancock Funds, where he was an Equity Analyst.

Nathan holds a Bachelor of Science from Babson College. He is a CFA® charterholder and a member of the CFA Society Boston.

Recent Insights

Diederik Basch, CFA®

Portfolio Manager

Diederik is a co-Portfolio Manager for the US Small Cap Strategy, which includes the Pax Small Cap Fund. Diederik started his investment analysis career in 2006 and has worked in the US, Europe and Asia.

Before joining Impax in 2016, Diederik served as Senior Equity Analyst at RobecoSAM AG, a subsidiary of Robeco Group, in Zurich, Switzerland, where he conducted fundamental research, including integration of ESG factors, on the global consumer staples and discretionary sectors. He was a key supporting analyst for the firm’s thematic Sustainable Healthy Living and Sustainable Agribusiness funds. Diederik also completed an assignment in Robeco’s Hong Kong office, working with its Asian Equities team. Prior to RobecoSAM, he was a Senior Associate Analyst at Canaccord Genuity, with a focus on small- and mid-cap companies.

Diederik is a CFA® charterholder and member of the Boston Security Analysts Society. He holds a Bachelor of Arts with a concentration in economics from Brandeis University. Diederik received his MBA from the Kelley School of Business at Indiana University, where he was also a faculty-selected member of the Investment Management Academy.

Recent Insights

Curtis Kim, CFA®

Portfolio Manager

Curtis is a co-Portfolio Manager for the US Small Cap Strategy, which includes the Pax Small Cap Fund.

Prior to joining the firm in 2018, Curtis served as a Generalist Analyst at SGF Capital, a long-short hedge fund focused on small cap equities. He also worked as a Quantitative Associate at Clearbridge Investments, a Legg Mason subsidiary. Curtis joined the investment industry in 2005 at FactSet Research Systems in the role of Product Specialist.

Curtis earned a Bachelor of Arts with a concentration in political science from Colgate University. He received an MBA from Cornell University and is a CFA® charterholder.

Recent Insights

Scroll to top
User Agent: CCBot/2.0 (https://commoncrawl.org/faq/)